Sponsor intelligence · INDUSTRY
Clinical trials sponsored by
Ambros Therapeutics, Inc..
Real, source-linked trial activity for Ambros Therapeutics, Inc.: 1 tracked trials, by phase and status, newest first. New trials = pipeline expansion = CRO, site, and reagent demand.
✔ Verified against the public NIH RePORTER & ClinicalTrials.gov records as of Oct 6, 2026. Source-linked, daily-refreshed.
PHASE3 1
Newest Ambros Therapeutics, Inc. trials
| Posted | Trial | Phase | Status | |
|---|---|---|---|---|
| 2d ago | Phase 3, Open-Label Extension Study of AMBTX-01 (Neridronate) for Comp | Ph 3 | NOT_YET_RECRUITING | ↗ |
Get this lane pushed to you the day a new grant or trial lands
Free email digest + a daily new-funding feed (JSON / MCP / webhook) of newly-awarded NIH grants and newly-registered clinical trials for Ambros Therapeutics, Inc. (trial sponsor). Watch institutions, PIs, sponsors, and topics. Newly-funded labs = new buyers, today.